Jazz Pharmaceuticals plc - SHS USD (JAZZ)

CUSIP: G50871105

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / SHS USD
Total 13F shares
60,646,127
Share change
-1,236,869
Total reported value
$7,990,617,646
Put/Call ratio
21%
Price per share
$131.80
Number of holders
498
Value change
-$150,715,669
Number of buys
215
Number of sells
254

Quarterly Holders Quick Answers

What is CUSIP G50871105?
CUSIP G50871105 identifies JAZZ - Jazz Pharmaceuticals plc - SHS USD in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q3 2025

As of 30 Sep 2025, Jazz Pharmaceuticals plc - SHS USD (JAZZ) was held by 498 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 60,646,127 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock, Inc., DIMENSIONAL FUND ADVISORS LP, Capital World Investors, LSV ASSET MANAGEMENT, STATE STREET CORP, JPMORGAN CHASE & CO, AMERIPRISE FINANCIAL INC, EcoR1 Capital, LLC, and FULLER & THALER ASSET MANAGEMENT, INC.. This page lists 498 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.